Total planned funding: $245,252,715
Allocations
Countries/Regions
| Eswatini | $245,252,715 |
Organizational Types
| Private Contractor | $64,457,585 |
| Unknown | $48,282,854 |
| NGO | $38,419,316 |
| University | $38,215,794 |
| Own Agency | $28,903,521 |
| FBO | $10,859,730 |
| Host Country Government Agency | $6,981,742 |
| Multi-lateral Agency | $5,708,202 |
| Other USG Agency | $3,423,971 |
| Implementing Agency | $0 |
Program Areas
| Treatment | $75,029,354 |
| Care | $58,943,057 |
| Prevention | $48,959,006 |
| Governance and Systems | $23,565,657 |
| Management and Operations | $19,535,281 |
| Testing | $19,220,360 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $61,032,836 |
| HKID: Care: Orphans and Vulnerable Children | $23,335,168 |
| HBHC: Care: Adult Care and Support | $22,334,572 |
| HVMS: Management and Operations | $19,535,281 |
| HVCT: Testing: HIV Testing and Counseling | $19,220,360 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $17,606,559 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $14,104,195 |
| HVTB: Care: TB/HIV | $10,895,823 |
| OHSS: Health Systems Strengthening | $10,855,412 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $10,628,146 |
| HTXD: Treatment: ARV Drugs | $8,955,541 |
| HVSI: Strategic Information | $8,227,318 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $6,546,320 |
| PDTX: Treatment: Pediatric Treatment | $5,040,977 |
| HLAB: Laboratory Infrastructure | $4,482,927 |
| PDCS: Care: Pediatric Care and Support | $2,377,494 |
| HMBL: Biomedical Prevention: Blood Safety | $73,786 |
Top Partner Programs
Columbia University:
$30,025,915
Countries/Regions
Not Available:
$29,320,001
Countries/Regions
Pact, Inc.:
$27,329,262
Countries/Regions
Chemonics International:
$20,887,669
Countries/Regions